Innovex International, Inc. — Form 8-K
Filed August 10, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Innovex International executed an underwriting agreement with Barclays Capital on August 6, 2026, for a secondary offering of 5,000,000 shares of common stock at $28.71 per share. Selling stockholders include Amberjack Capital Fund II (3.7M shares), Innovex Co-Invest funds (1.1M shares combined), and Intervale Capital funds (222K shares combined). Proceeds go entirely to selling shareholders, not the company. Lock-up agreements restrict officer/director and selling shareholder sales for 45 days post-closing (August 10, 2026 closing date).
Why this rating
Secondary offering by existing shareholders; no capital raised by company. Offering size ~$143.5M is ~24% of $599M market cap—material in isolation but typical secondary/insider liquidity event. No business operations impact; proceeds don't fund company.
See more from August 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.